Applied Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Applied Therapeutics's estimated annual revenue is currently $8.4M per year.
- Applied Therapeutics's estimated revenue per employee is $139,500
- Applied Therapeutics's total funding is $239.1M.
Employee Data
- Applied Therapeutics has 60 Employees.
- Applied Therapeutics grew their employee count by 46% last year.
Applied Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Founder | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Operating Officer/Chief Business Officer | Reveal Email/Phone |
4 | Chief Commercial Officer | Reveal Email/Phone |
5 | Chief Regulatory Officer | Reveal Email/Phone |
6 | CFO | Reveal Email/Phone |
7 | Chief Business Officer / Chief Operating Officer | Reveal Email/Phone |
8 | Chief Commercial Officer | Reveal Email/Phone |
9 | VP Chemistry, Manufacturing and Formulation | Reveal Email/Phone |
10 | Area Director, East | Reveal Email/Phone |
Applied Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 4 | 0% | N/A | N/A |
#2 | $3.7M | 24 | 41% | $44M | N/A |
#3 | $6.2M | 40 | -7% | N/A | N/A |
#4 | $42M | 271 | -1% | N/A | N/A |
#5 | $12.7M | 82 | 0% | $10M | N/A |
#6 | $2.5M | 16 | 0% | N/A | N/A |
#7 | $7.5M | 45 | 0% | $51.6M | N/A |
#8 | $0.2M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 26 | -16% | $3.3M | N/A |
#10 | $3.7M | 24 | 4% | N/A | N/A |
What Is Applied Therapeutics?
Applied Therapeutics is a clinical-stage biopharmaceutical company that uses our novel drug-development approach to create transformative, life-changing treatments for the patients who desperately need them.
keywords:N/A$239.1M
Total Funding
60
Number of Employees
$8.4M
Revenue (est)
46%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Applied Therapeutics News
2022-04-13 - Applied Therapeutics (NASDAQ:APLT) PT Lowered to $6.00
Citigroup upped their price objective on shares of Applied Therapeutics from $30.00 to $38.00 and gave the company a buy rating in a research...
2022-04-06 - Where Does Applied Therapeutics Inc (APLT) Stock Fall in the Biotechnology
Field After It Is Down -12.05% This Week?
The 35 rating InvestorsObserver gives to Applied Therapeutics Inc (APLT) stock puts it near the bottom of the Biotechnology industry.
2022-03-30 - Applied Therapeutics to Present at the 43rd Annual Meeting of ...
Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $13.5M | 60 | 18% | N/A |
#2 | $13.5M | 60 | -6% | N/A |
#3 | $3.5M | 60 | -8% | N/A |
#4 | $14.6M | 60 | 20% | N/A |
#5 | $7.3M | 60 | -3% | $86.7M |